Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Tetragenus active bacterial agent for treating diarrhoea and application of tetragenus active bacterial agent

A live bacteria preparation and diarrhea technology, applied in the field of medicine, can solve problems such as uneven products, dog intestinal flora imbalance, and no microecological preparations for dogs, etc., to inhibit pathogenic bacteria, improve body immunity, improve The effect of gut microbiota structure

Inactive Publication Date: 2019-12-31
JIANGSU HFQ BIO TECH CO LTD
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At the same time, some non-infectious factors such as excessively fast and frequent dietary changes, improper nutritional structure, environmental stress and other exogenous factors can also cause intestinal flora imbalance in dogs.
[0003] However, at present, the products of probiotics for dogs in the domestic market are uneven, and there are no probiotics for dogs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tetragenus active bacterial agent for treating diarrhoea and application of tetragenus active bacterial agent
  • Tetragenus active bacterial agent for treating diarrhoea and application of tetragenus active bacterial agent
  • Tetragenus active bacterial agent for treating diarrhoea and application of tetragenus active bacterial agent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] A quadruple active bacterial preparation for treating diarrhea, comprising 5% probiotic mixture, 6% xylooligosaccharide, and the balance being glucose;

[0015] The probiotic mixture includes freeze-dried powder of Bifidobacterium animalis, freeze-dried powder of Lactobacillus paracasei, freeze-dried powder of Enterococcus faecium and freeze-dried powder of Saccharomyces cerevisiae.

[0016] The live bacteria ratio of Bifidobacterium animalis, Lactobacillus paracasei, Enterococcus faecium and Saccharomyces cerevisiae is 10:10:1:1.

[0017] The number of live bacteria of Bifidobacterium animalis B1014 strain ≥ 2.0×10 9 CFU / g, live bacteria count of Lactobacillus paracasei L1056 strain ≥2.0×10 9 CFU / g, the number of live bacteria of Enterococcus faecium EF1012 strain ≥ 2.0×10 8 CFU / g, the number of live bacteria of Saccharomyces cerevisiae S1072 strain ≥2.0×10 8 CFU / g.

[0018] The survival rate of Lactobacillus paracasei, Enterococcus faecium and Saccharomyces cerevi...

Embodiment 2

[0021] A quadruple active bacterial preparation for treating diarrhea, comprising 50% probiotic mixture, 10% xylooligosaccharide, and the balance being glucose;

[0022] The probiotic mixture includes freeze-dried powder of Bifidobacterium animalis, freeze-dried powder of Lactobacillus paracasei, freeze-dried powder of Enterococcus faecium and freeze-dried powder of Saccharomyces cerevisiae.

[0023] The live bacteria ratio of Bifidobacterium animalis, Lactobacillus paracasei, Enterococcus faecium and Saccharomyces cerevisiae is 5:5:1:1.

[0024] The number of live bacteria of Bifidobacterium animalis B1014 strain ≥ 2.0×10 9 CFU / g, live bacteria count of Lactobacillus paracasei L1056 strain ≥2.0×10 9 CFU / g, the number of live bacteria of Enterococcus faecium EF1012 strain ≥ 2.0×10 8 CFU / g, the number of live bacteria of Saccharomyces cerevisiae S1072 strain ≥2.0×10 8 CFU / g.

[0025] The survival rate of Lactobacillus paracasei, Enterococcus faecium and Saccharomyces cerevi...

Embodiment 3

[0028] A quadruple active bacterial preparation for treating diarrhea, comprising 25% probiotic mixture, 8% xylooligosaccharide, and the balance being glucose;

[0029] The probiotic mixture includes freeze-dried powder of Bifidobacterium animalis, freeze-dried powder of Lactobacillus paracasei, freeze-dried powder of Enterococcus faecium and freeze-dried powder of Saccharomyces cerevisiae.

[0030] The live bacteria ratio of Bifidobacterium animalis, Lactobacillus paracasei, Enterococcus faecium and Saccharomyces cerevisiae was 15:15:2:2.

[0031] The number of live bacteria of Bifidobacterium animalis B1014 strain ≥ 2.0×10 9 CFU / g, live bacteria count of Lactobacillus paracasei L1056 strain ≥2.0×10 9 CFU / g, the number of live bacteria of Enterococcus faecium EF1012 strain ≥ 2.0×10 8 CFU / g, the number of live bacteria of Saccharomyces cerevisiae S1072 strain ≥2.0×10 8 CFU / g.

[0032] The survival rate of Lactobacillus paracasei, Enterococcus faecium and Saccharomyces cere...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a tetragenus active bacterial agent for treating diarrhoea and an application of the tetragenus active bacterial agent. The tetragenus active bacterial agent comprises 5-50% ofa probiotic mixture, 6-10% of Xylo-oligosaccharides and the balance glucose, wherein the probiotic mixture comprises animal bifidobacteria freeze-dried powder, lactobacillus paracasei freeze-dried powder, enterococcus faecium freeze-dried powder and saccharomyces cerevisiae freeze-dried powder. A bifidobacteria, lactobacilli, enterococcus faecium and accharomyces cerevisiae composite viable bacteria preparation is used for treating diarrhoea caused by alteration of intestinal floras of dogs, and the products have obvious treatment effects on the diarrhoea symptoms caused by the alteration ofintestinal floras of the dogs. The four bacteria of the bifidobacteria, the lactobacilli, the enterococcus faecium and the accharomyces cerevisiae have good effects of resisting acid resistance and resisting cholate, the composition can effectively improve the flora structure of intestines, can restrain pathogenic bacteria, can increase the beneficial floras of intestines, can improve the immunityof organisms, and can achieve the effects of preventing diseases and treating diseases.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a quadruple active bacteria preparation for treating diarrhea and its application. Background technique [0002] The balance of flora in the intestinal tract of animals has an important impact on the health of the digestive tract. In the pet market represented by canine animals, the mainstream drugs are antibiotics. Although it has well controlled the development of various pathogenic bacteria for a period of time, such as Campylobacter jejuni, E. The disadvantages of antibiotics are gradually emerging, such as the emergence of drug-resistant pathogens, drug residues in livestock products, and antibiotics can also eliminate sensitive beneficial bacteria that have a protective barrier and antagonize external bacteria, aggravating the imbalance of flora, and then producing such as Vomiting, diarrhea, loss of appetite and other typical symptoms of a series of intestinal flora dis...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/064A61P1/12A61P31/04A61P37/04A61K35/745A61K35/747A61K35/744
CPCA61K35/744A61K35/745A61K35/747A61K36/064A61P1/12A61P31/04A61P37/04A61K2300/00
Inventor 德艳艳廖洪张艳花
Owner JIANGSU HFQ BIO TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products